Free tool
FAERS Monitor: Octreoscan
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020314 or its brand name (Octreoscan, Indium In-111 Pentetreotide Kit). Reports on generic versions are filed under their own applications.
Reports
128
Serious
87
68% of reports
Hospitalization
23
Death reported
42
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- intentional drug misuse31
- death21
- haemoglobin abnormal16
- nausea15
- drug ineffective14
- platelet disorder10
- product use issue10
- disease progression8
- product use in unapproved indication8
- blood bilirubin abnormal7
- haematotoxicity7
- pyrexia7
- diarrhoea6
- flushing6
- malignant neoplasm progression6
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 17 |
| 2010 | 37 |
| 2011 | 3 |
| 2012 | 4 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 1 |
| 2020 | 21 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,031 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood bilirubin abnormalSignal | 7 | 903.8 | 438.9 | 5,412 |
| platelet disorderSignal | 10 | 654.3 | 360.4 | 5,863 |
| haemoglobin abnormalSignal | 16 | 409.7 | 258.9 | 6,108 |
| intentional drug misuseSignal | 31 | 244.0 | 179.5 | 7,257 |
| haematotoxicitySignal | 7 | 121.1 | 58.9 | 718 |
| disease progressionSignal | 8 | 11.1 | 5.7 | 64 |
| flushingSignal | 6 | 9.7 | 4.4 | 39 |
| malignant neoplasm progressionSignal | 6 | 9.6 | 4.4 | 38 |
| product use issueSignal | 10 | 8.7 | 4.8 | 62 |
| product use in unapproved indicationSignal | 8 | 5.3 | 2.7 | 24 |
| deathSignal | 21 | 4.0 | 2.7 | 46 |
| pyrexiaSignal | 7 | 3.3 | 1.6 | 9 |
| nauseaSignal | 15 | 3.1 | 1.9 | 20 |
| drug ineffective | 14 | 1.7 | 1.1 | 4 |
| diarrhoea | 6 | 1.5 | 0.7 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.